SANGHRAJKA ASHISH P enters SCOPUS BIOPHARMA INC. with 190K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 12/15/2020ACC: 0001104659-20-135876
DirectorOfficer· President
Since Dec 2020
190K
Baseline shares
100% direct
190K
Direct ownership
1 position
436.70K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock, par value $0.001
DirectShares owned190K
Total
190K direct190K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.001 | 190K | Direct |
| Total | 190K | 190K direct |
Derivative Holdings2
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
300K
Shares owned
N/A
Exercise price
3.00
Expiration
—
Exercise window
—
W Warrant
DirectUnderlying security
B Unit
Underlying shares
136.70K
Shares owned
N/A
Exercise price
4.00
Expiration
—
Exercise window
—
Total
Underlying
436.70K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Options Direct | Common Stock | 3.00 | — | — | 300K | N/A |
| W Warrant Direct | B Unit | 4.00 | — | — | 136.70K | N/A |
| Total | 436.70K | 0.00 | ||||